194 related articles for article (PubMed ID: 26023151)
1. How Can We Identify the Elimination of Infectious Diseases? Experience From an Active Measles Laboratory Surveillance System in the Republic of Korea.
Yang TU; Kang HJ; Eom HE; Park YJ; Park O; Kim SJ; Nam JG; Kim SS; Jeong EK
Asia Pac J Public Health; 2015 Nov; 27(8 Suppl):101S-109S. PubMed ID: 26023151
[TBL] [Abstract][Full Text] [Related]
2. Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea.
Choe YJ; Jee Y; Oh MD; Lee JK
J Korean Med Sci; 2015 Nov; 30 Suppl 2(Suppl 2):S115-21. PubMed ID: 26617443
[TBL] [Abstract][Full Text] [Related]
3. Progress Toward Measles Elimination - Bangladesh, 2000-2016.
Khanal S; Bohara R; Chacko S; Sharifuzzaman M; Shamsuzzaman M; Goodson JL; Dabbagh A; Kretsinger K; Dhongde D; Liyanage J; Bahl S; Thapa A
MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(28):753-757. PubMed ID: 28727678
[TBL] [Abstract][Full Text] [Related]
4. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
5. Progress Toward Measles Elimination - Nepal, 2007-2014.
Khanal S; Sedai TR; Choudary GR; Giri JN; Bohara R; Pant R; Gautam M; Sharapov UM; Goodson JL; Alexander J; Dabbagh A; Strebel P; Perry RT; Bah S; Abeysinghe N; Thapa A
MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(8):206-10. PubMed ID: 26937619
[TBL] [Abstract][Full Text] [Related]
6. [Molecular surveillance shows progress in measles elimination process].
Santibanez S; Mankertz A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1238-42. PubMed ID: 23990085
[TBL] [Abstract][Full Text] [Related]
7. Progress towards measles elimination, Philippines, 1998–2014.
Wkly Epidemiol Rec; 2015 Apr; 90(15):149-59. PubMed ID: 25864232
[No Abstract] [Full Text] [Related]
8. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
[TBL] [Abstract][Full Text] [Related]
9. Successful control and impending elimination of measles in the Islamic Republic of Iran.
Zahraei SM; Gouya MM; Azad TM; Soltanshahi R; Sabouri A; Naouri B; Alexander JP
J Infect Dis; 2011 Jul; 204 Suppl 1():S305-11. PubMed ID: 21666178
[TBL] [Abstract][Full Text] [Related]
10. Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission.
Choi WS; Sniadack DH; Jee Y; Go UY; So JS; Cho H; Bae GR; Lee DH; Kim K; Yoon HS; Chung YS; Kang C; Park H; Park O; Lee JK
J Infect Dis; 2011 Jul; 204 Suppl 1():S483-90. PubMed ID: 21666204
[TBL] [Abstract][Full Text] [Related]
11. Progress towards measles elimination -South-East Asia Region, 2003-2013.
Wkly Epidemiol Rec; 2015 Jun; 90(24):297-305. PubMed ID: 26072524
[No Abstract] [Full Text] [Related]
12. Is measles elimination possible in WHO European region up to 2015?
Paslawska A; Mrozek-Budzyn D
Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
[TBL] [Abstract][Full Text] [Related]
13. Progress toward the 2012 measles elimination goal--Western Pacific Region, 1990-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):669-73. PubMed ID: 19553903
[TBL] [Abstract][Full Text] [Related]
14. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.
Coughlin MM; Beck AS; Bankamp B; Rota PA
Viruses; 2017 Jan; 9(1):. PubMed ID: 28106841
[TBL] [Abstract][Full Text] [Related]
15. Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms.
Mulders MN; Serhan F; Goodson JL; Icenogle J; Johnson BW; Rota PA
J Infect Dis; 2017 Jul; 216(suppl_1):S324-S330. PubMed ID: 28838191
[TBL] [Abstract][Full Text] [Related]
16. Progress towards measles elimination – African Region, 2013–2016.
Wkly Epidemiol Rec; 2017 May; 92(18):229-39. PubMed ID: 28530366
[No Abstract] [Full Text] [Related]
17. Measles - The epidemiology of elimination.
Durrheim DN; Crowcroft NS; Strebel PM
Vaccine; 2014 Dec; 32(51):6880-6883. PubMed ID: 25444814
[TBL] [Abstract][Full Text] [Related]
18. Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.
Dabbagh A; Patel MK; Dumolard L; Gacic-Dobo M; Mulders MN; Okwo-Bele JM; Kretsinger K; Papania MJ; Rota PA; Goodson JL
MMWR Morb Mortal Wkly Rep; 2017 Oct; 66(42):1148-1153. PubMed ID: 29073125
[TBL] [Abstract][Full Text] [Related]
19. Development of the Global Measles Laboratory Network.
Featherstone D; Brown D; Sanders R
J Infect Dis; 2003 May; 187 Suppl 1():S264-9. PubMed ID: 12721924
[TBL] [Abstract][Full Text] [Related]
20. Effects of COVID-19 on the laboratory turn-around time of vaccine-preventable disease surveillance: the case of measles in South Sudan.
Kunjok DM; Zingbondo IM
Pan Afr Med J; 2020; 37():245. PubMed ID: 33552363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
